Patients with type 2 diabetes who switched to tirzepatide rather than escalating their dulaglutide dosage had greater weight ...

Switching to tirzepatide associated with hemoglobin A1c reduction and weight loss compared with escalating treatment with dulaglutide.

Type 2 diabetes mellitus (T2DM) is a major public health challenge in India, with an estimated 101 million individuals ...

Munich news, health insurance, technology, jobs and other topics for expatriates. The Eye Newspapers covers daily news and offers services for foreigners.

Diabetes patients on dulaglutide (Trulicity) had better glycemic control and more weight loss if they switched to tirzepatide ...

The study finds better A1c lowering and weight reduction, but an expert clinician says practical issues may pose barriers.

ATTD conference, experts debated whether patients who use continuous glucose monitoring should aim for normal glycemia.

The tests used to check for prediabetes or diabetes can help determine a diagnosis. The A1C test is a blood test that measures the percentage of sugar attached to hemoglobin, a protein in red ...

AID therapy resulted in a mean HbA1c reduction of 0.9 percentage points over 13 weeks, while the control group experienced a 0.3 percentage point reduction. Automated insulin delivery systems have ...